Healthcare news, data and analysis
Via Investors in Healthcare
France: Cathay Innovation closes US$1bn VC fund to bring vertical AI to critical industries
Cathay Innovation has announced the final close of its latest venture capital fund (Fund III) at US$1bn, making it the largest AI-dedicated fund out of the European Union. The France-headquartered fund […]
Cathay Innovation has announced the final close of its latest venture capital fund (Fund III) at US$1bn, making it the largest AI-dedicated fund out of the European Union. The France-headquartered fund […]
France: Cathay Innovation closes US$1bn VC fund to bring vertical AI to critical industries
May 29, 2025
Life Sciences
Manufacturing – Specialty Pharma
Medtech – Healthcare IT
News
Pharma
Mercalis, an integrated life sciences commercialization partner, has merged with PharmaCord, a provider of patient services for the biopharmaceutical industry, and rebranded as Valeris. The combined platform – backed by […]
Euronext and Nasdaq-listed global healthcare company, Sanofi, has entered into an agreement to acquire US-listed Vigil Neuroscience, a publicly traded clinical-stage biotechnology company focused on developing novel therapies for neurodegenerative […]
SIX-listed Galderma, the pure-play dermatology company, has agreed to repurchase 2.38 million shares at a price of CHF97.75 per share for a total consideration of CHF232.5m (US$281.2m) in the context of the accelerated bookbuild […]
Diaverum, the Swedish-born global renal care provider, has acquired full ownership of IMU Dialysis in Kuala Lumpur, its first acquisition in Malaysia since entering the market. The clinic has been […]
Alantra, a global alternative asset management, investment banking, and credit portfolio advisory firm, acted as exclusive financial advisor to Perrigo Company on the divestment of Richard Bittner – a specialist […]
Asia-based healthcare-focused private equity firm, Quadria Capital, has announced the final close of its Fund III with US$1.07bn in total commitments, exceeding its original US$800m target. The fundraise comprises over […]
European investor CVC is selling its stake in Genetic, an Italy-based CDMO focused on the development and supply of products into the respiratory, ophthalmic and oncology therapeutic areas, to Renaissance […]
UK-headquartered PE firm Cinven has revealed it is in exclusive negotiations with Canada-based Sagard MidCap to acquire France-based Nutrisens, alongside CEO & founder Georges Devesa and its management team. Nutrisens, […]
Lars Fruergaard Jørgensen is stepping down from the CEO role at global healthcare company Novo Nordisk by mutual agreement. The search for a successor is ongoing. In connection with the […]
Famar Group, an Greece-based European pharmaceutical CDMO, is acquiring a sterile production site in Homburg (Saar), Germany, from MiP Pharma, a marketer of prescription generics, primarily antibiotics, over-the-counter medicines and […]
Inflexion, a European mid-market private equity firm, has announced the successful close of Inflexion Continuation Fund I at £2.3bn (US$3.06bn), its first continuation fund and the largest multi-asset continuation fund […]
KSA-based Specialized Medical Company (SMC Hospitals), a leading multi-specialist healthcare provider consisting of over 600 inpatient beds and over 250 outpatient clinics, has announced its intention to IPO and list […]
Stow Healthcare Group, a privately held residential care group that owns and operates a collection of exclusive nursing, residential and memory care homes in the East of England, has been sold […]
European private equity firm, Luxembourg-headquartered Astorg, has announced an evolution of its leadership team as part of its long-term development strategy. Thierry Timsit, co-founder of the firm and currently CEO, […]
Mansfield Advisors, the UK-based strategy consulting firm across healthcare (including social care and education), life sciences and veterinary, has promoted Ali Bahram to associate partner. Bahram has been with Mansfield […]
Metric Capital Partners, a pan-European private capital investment firm, has announced the final close of MCP V and its ancillary vehicles at its target size with total commitments of €1bn […]
Funds advised by Nord Holding have acquired Rigeto’s stake in OR Technology, a provider of digital X-ray imaging and image management systems and becomes a strategic partner to OR’s management […]
Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, has completed an oversubscribed €132m (US$147m) Series B financing […]
Riverside, a US-based global investment firm focused on the smaller end of the middle market, has announced that its portfolio company, BioDue, an Italian CDMO specialized in the commercialization of food […]
Switerland headquartered online pharmacy, DocMorris, is looking to raise around CHF200m (US$237m) through a rights issue. The capital increase will be used to finance the planned medium-term growth in the […]
Safe Life, a Stockholm-based provider of life-saving solutions with portfolio companies across Europe and North America, has been on an acquisition spree as it pursues its ambitious growth strategy across Europe and beyond. The […]
Spain-based Miura Partners has provided a capital increase for Barcelona-headquartered Saesco Medical, a European group specialised in the distribution of medical devices and consumables for minimally invasive surgery, in support […]
News reports, referencing Bloomberg, point to Bain Capital looking to acquire PCI Pharma Services for US$10bn. PCI Pharma is a US-based global CDMO backed by Kohlberg, Mubadala Investment Company and […]
01
Our People
A dedicated team of executive search experts, delivering for you
The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.
Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.
02
Expertise
Unearthing rare talent, that drive successful exits
Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.
03
Our Approach
Tailoring our offering,
to provide a bespoke service
Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.
A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors
What our clients say
“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”
Outcomes First Group – Chair
